Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC

NCT04238169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung Cancer Stage IV

Interventions

DRUG: Bevacizumab
DRUG: Toripalimab
RADIATION: SBRT

Sponsor

Xinqiao Hospital of Chongqing